SAFC Pharma, the fine chemicals business of Sigma-Aldrich saw a decline during Q3 as a result of spending cutbacks in the pharmaceutical sector. Kirk Richter, Sigma-Aldrich's Treasurer and Investor Relations executive, said that "customers have either deferred committed orders or not repeated the business we've enjoyed in the past". He did remain optimistic going forward.
Seeking Alpha
Wednesday 29 October 2008
SAFC sees decline
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment